Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $44.92 USD
Change Today -0.05 / -0.11%
Volume 176.2K
As of 8:04 PM 03/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jonathan White

Chief Science & Technology Officer, Haemonetics Corporation
AgeTotal Calculated CompensationThis person is connected to 5 board members in 1 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Jonathan White serves as Chief Scientific & Technology Officer of Haemonetics Corporation and served as its Vice President of Research & Development. Dr. White served as the Head of Research and Development and Vice President at Haemonetics Corp. since December 8, 2008. Prior to joining Haemonetics, Dr. White worked with Pfizer Inc. for 10 years in a variety of progressive roles encompassing: strategy and business development, leadership of the information technology ...

Read Full Background

Corporate Headquarters*

400 Wood Road
Braintree, Massachusetts 02184

United States

Phone: 781-848-7100
Fax: --

Board Members Memberships*



Master's Degree
University of Cambridge

Other Affiliations*

Annual Compensation*

Total Annual Compensation$441,000

Stock Options*

Restricted Stock Awards$1,062,980
All Other Compensation$6,600
Exercisable Options122,432
Exercisable Options Value$341,915
Unexercisable Options91,903
Unexercisable Options Value$60,237
Total Value of Options$402,152
Total Number of Options214,335

Total Compensation*

Total Annual Cash Compensation$497,213
Total Short Term Compensation$441,000
Other Long Term Compensation$1,069,580
Total Calculated Compensation$1,767,897
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HAE:US $44.92 USD -0.05


Omar S. Ishrak Chairman and Chief Executive Officer
Medtronic plc
Neal L. Patterson Co-Founder, Chairman and Chief Executive Officer
Cerner Corporation
John H. Hammergren Chairman, Chief Executive Officer and President
McKesson Corporation
Yutaro Shintaku President and Representative Director
Terumo Corporation
Ulf Mark Schneider Chairman of the Management Board - Fresenius Management Se, Chief Executive Officer of Fresenius Management Se and President of Fresenius Management Se
Fresenius SE & Co KGaA
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HAEMONETICS CORP/MASS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at